Powered by

Versantis Appoints Seasoned Pharma Executive Christopher Seaton to Board

Feb 05, 2021 - Business Wire
Board and Executive Moves

Versantis AG, a clinical-stage company developing novel therapies for orphan liver diseases, today announced the appoint of seasoned pharmaceutical executive Christopher Seaton to its Board of Directors. Mr. Seaton has extensive expertise in business development, with more than 25 years experience in closing transactions of all types, including M&A, licensing, collaborations and partnerships. He also has varied hospital and healthcare board position experience.

"Christopher is a very exper...